Calculous Pyelonephritis Management

Clinical Presentation and Diagnosis

Patients with calculous pyelonephritis typically present with fever, chills, flank pain, nausea, vomiting, and lower urinary tract symptoms, and in severe cases, signs of sepsis or septic shock, according to the European Urology and Journal of the American College of Radiology guidelines 1, 2
Laboratory evaluation, including urinalysis, urine culture with antimicrobial susceptibility testing, blood cultures, and serum inflammatory markers, is essential for diagnosis and management, as recommended by the European Urology and Journal of the American College of Radiology guidelines 1, 2

Ultrasound is the first-line imaging modality to detect hydronephrosis and possible pus presence, while CT with contrast is the most sensitive for confirming diagnosis and determining the cause of obstruction, with findings including parenchymal changes, hydronephrosis, perinephric stranding, and visualization of the obstructing stone, according to the Journal of the American College of Radiology guideline 2, 3

Urgent decompression of the collecting system is recommended in obstructive calculous pyelonephritis, which can be achieved through percutaneous nephrostomy or ureteral stent placement, as supported by the American College of Radiology and European Urology guidelines 1
Antimicrobial therapy is recommended, with oral fluoroquinolones or trimethoprim/sulfamethoxazole for outpatient treatment and initial intravenous antimicrobial regimen for inpatient treatment, including fluoroquinolone, aminoglycoside, or extended-spectrum cephalosporin/penicillin, with carbapenems reserved for patients with multidrug-resistant organisms, as recommended by the European Urology guideline 1
The duration of antimicrobial therapy is 5-14 days, depending on clinical response and antimicrobial agent, as supported by the European Urology guideline 1

Patients who do not respond to treatment within 48-72 hours should undergo repeat imaging, repeat cultures, and consideration of alternative diagnoses, as recommended by the Journal of the American College of Radiology guideline 2
Certain patient populations, including those with diabetes, urinary tract obstruction, immunocompromised status, anatomical anomalies of the urinary tract, and vesicoureteral reflux, are at higher risk of developing complications such as pionefrosis, as reported by the American College of Radiology 3
Pionefrosis requires urgent management, including immediate decompression of the collecting system via percutaneous nephrostomy or ureteral catheter, intravenous broad-spectrum antibiotics, and treatment of the underlying cause, as stated by the American College of Radiology 3
Broad-spectrum intravenous antibiotics, such as fluoroquinolones or trimethoprim-sulfamethoxazole, are recommended for 5-7 or 14 days, respectively, based on antibiogram results, as recommended by the Annals of Internal Medicine 4
If left untreated, pionefrosis can lead to severe complications, including permanent renal damage, scarring, hypertension, chronic renal failure, sepsis, shock, and renal or perirenal abscesses, as warned by the American College of Radiology 3